210520 US Pre OPen
US Futures consolidating, watch EXPE, MDT, TTWO, BBY, LB
Later today, U.S. Initial Jobless Claims
(a decline to 2.400 million expected), the Markit U.S. Manufacturing Purchasing Managers' Index (May preliminary reading, 39.5 expected), Existing Home Sales (an annualized rate of 4.22 million units for April expected) and the Conference Board Leading Index (-5.4% on month in April expected) will be reported. Markit May Manufacturing PMI is expected at 39.5 and the May Services PMI is expected at 32.3.
European indices are on posting a consolidation move. Research firm Markit has published preliminary readings of May Manufacturing PMI for the eurozone at 39.5 (vs 38.0 expected), for Germany at 36.8 (vs 39.4 expected), for France at 40.3 (vs 36.0 expected) and for the U.K. at 40.6 (vs 37.2 expected). Also, preliminary readings of May Services PMI were publish for the eurozone at 28.7 (vs 25.0 expected), for Germany at 31.4 (vs 26.0 expected), for France at 29.4 (vs 28.0 expected) and for the U.K. at 27.8 (vs 24.0 expected).
Asian indices closed in the red. This morning, official data showed that Japan recorded a trade deficit of 996 billion yen in April (503 billion yen deficit expected), where exports declined 21.9% on year (-22.2% expected) and imports slid 7.2% (-13.2% expected).
WTI Crude Oil Futures remain on the upside. The U.S. Energy Information Administration (EIA) released a weekly report for May 15, which stated that U.S. commercial crude oil inventories (excluding those in the Strategic Petroleum Reserve) decreased by 5.0M barrels from the previous week to 526.5M barrels. Meanwhile, U.S. crude oil production fell to 11.5M b/d last week from 11.6M b/d in the prior period.
Gold fell 14.39$ (-0.82%) to 1733.8 as the US dollar strengthened. The dollar index rose 0.04pt to 99.16.
US Equity Snapshot
Expedia (EXPE), the online travel agency, disclosed first quarter adjusted LPS of 1.83 dollar, worse than expected, down from a LPS of 0.27 dollar a year ago, on sales of 2.2 billion dollars, just above the consensus, down from 2.6 billion dollars last year. The company said it «accelerated and expanded" its "ambition on improving long-term cost structure".
Medtronic (MDT), a developer and manufacturer of therapeutic medical devices, reported fourth quarter adjusted EPS down to 0.58 dollar, missing estimates, from 1.54 dollar a year earlier. Sales were down 26% to 6 billion dollars, also below forecasts.
Take-Two Interactive Software (TTWO), a leading global video game publisher, announced fourth quarter adjusted EPS of 1.50 dollar, beating estimates, up from 0.78 dollar a year ago, on sales of 729.4 million dollars, exceeding forecasts, up from 488.4 million dollars in the same prior year period. Yet, the stock lost ground in extended trading on profit taking as sales growth seen last quarter may fade after the end of lockdown.
Best Buy (BBY), the consumer electronics retailer, unveiled first quarter same-store sales down 5.3%, beating consensus. Adjusted EPS fell to 0.67 dollar from 1.02 dollar a year earlier, above forecasts.
L Brands (LB), a women's apparel and beauty products retailer, posted first quarter adjusted LPS of 0.99 dollar, below estimates, vs a LPS of 0.15 dollar a year ago, on sales of 1.7 billion dollars, also missing the forecast, down from 2.6 billion dollars in the same previous year period.
Source: TradingVIEW, Gain Capital
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.
City Index is a trading name of StoneX Financial Pty Ltd.
The material provided herein is general in nature and does not take into account your objectives, financial situation or needs.
While every care has been taken in preparing this material, we do not provide any representation or warranty (express or implied) with respect to its completeness or accuracy. This is not an invitation or an offer to invest nor is it a recommendation to buy or sell investments.
StoneX recommends you to seek independent financial and legal advice before making any financial investment decision. Trading CFDs and FX on margin carries a higher level of risk, and may not be suitable for all investors. The possibility exists that you could lose more than your initial investment further CFD investors do not own or have any rights to the underlying assets.
It is important you consider our Financial Services Guide and Product Disclosure Statement (PDS) available at www.cityindex.com/en-au/terms-and-policies/, before deciding to acquire or hold our products. As a part of our market risk management, we may take the opposite side of your trade. Our Target Market Determination (TMD) is also available at www.cityindex.com/en-au/terms-and-policies/.
StoneX Financial Pty Ltd, Suite 28.01, 264 George Street, Sydney, NSW 2000 (ACN 141 774 727, AFSL 345646) is the CFD issuer and our products are traded off exchange.
© City Index 2024